IOL Chemicals and Pharmaceuticals Limited announced that the China's Drug Regulatory Authority viz National Medical Products Administration (NMPA), China has approved the product "Fenofibrate" manufactured by the Company. This will enable the Company to export its Fenofibrate API in China market. Fenofibrate is used to treat high cholesterol and triglyceride levels in the blood.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
414.6 INR | -0.73% | -1.38% | -10.51% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.51% | 29Cr | |
+55.35% | 82TCr | |
+31.94% | 60TCr | |
-0.10% | 38TCr | |
+15.47% | 32TCr | |
+13.10% | 31TCr | |
+16.13% | 25TCr | |
+14.53% | 23TCr | |
+16.54% | 18TCr | |
+4.31% | 17TCr |
- Stock Market
- Equities
- IOLCP Stock
- News IOL Chemicals and Pharmaceuticals Limited
- IOL Chemicals and Pharmaceuticals Limited Announces National Medical Products Administration, China Approves Fenofibrate